sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 526-550 out of 1406.

<< < 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 > >>

Public Release: 15-Feb-2017
Molecular Psychiatry
Bipolar disorder candidate gene, validated in mouse experiment
Researchers at Ulsan National Institute of Science and Technology (UNIST) in South Korea has made a significant breakthrough in the search for the potential root causes of bipolar disorder.
Future Creation Science Department, Korea Research Foundation

Contact: JooHyeon Heo
joohyeonheo@unist.ac.kr
82-522-171-223
Ulsan National Institute of Science and Technology(UNIST)

Public Release: 15-Feb-2017
Bioinformatics
Ebolaviruses need very few mutations to cause disease in new host species
Ebola is one of the world's most virulent diseases, though rodent species such as guinea pigs, rats and mice are not normally susceptible to it. However, through repeated infection of a host animal, Ebola virus strains can be generated that replicate and cause disease within new host rodent species.

Contact: Sandy Fleming
S.Fleming@kent.ac.uk
44-012-278-23581
University of Kent

Public Release: 15-Feb-2017
Nature
New malaria vaccine effective in clinical trial
University of Tuebingen researchers in collaboration with the biotech company Sanaria Inc. have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria® PfSPZ-CVac has been up to 100 percent effective when assessed at 10 weeks after last dose of vaccine. For the trial, Professor Peter Kremsner and Dr. Benjamin Mordmueller of the Institute of Tropical Medicine and the German Center for Infection Research used malaria parasites provided by Sanaria.

Contact: Peter Kremsner
peter.kremsner@uni-tuebingen.de
49-707-129-87179
German Center for Infection Research

Public Release: 15-Feb-2017
Science Translational Medicine
International study suggests Nodding syndrome caused by response to parasitic protein
Researchers at the National Institutes of Health have uncovered new clues to the link between Nodding syndrome, a devastating form of pediatric epilepsy found in specific areas of east Africa, and a parasitic worm that can cause river blindness. The study, published in Science Translational Medicine, suggests that the mysterious neurological disease may be caused by an autoimmune response to the parasitic proteins.
National Institutes of Health

Contact: Barbara McMakin
nindspressteam@ninds.nih.gov
NIH/National Institute of Neurological Disorders and Stroke

Public Release: 15-Feb-2017
European Journal of Preventive Cardiology
Statin side effects are strongest predictor of failure to meet cholesterol targets
Statin side effects are the strongest predictor of failure to meet low-density lipoprotein (LDL) cholesterol targets, according to research published today in the European Journal of Preventive Cardiology. Other predictors were statin non-adherence and use of weaker statins.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 14-Feb-2017
Retrovirology
Only a limited HIV subset moves from mother to child, study shows
In the transmission of HIV-1 from mother to child only a subset of a mother's viruses infects their infants either in utero or via breastfeeding, and the viruses that are transmitted depend on whether transmission occurs during pregnancy or through breastfeeding
National Institutes of Health, NIH/National Institute of Child Health and Human Development, International Maternal Pediatric Adolescent AIDS Trials Group

Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-267-7120
University of California - Los Angeles Health Sciences

Public Release: 14-Feb-2017
Conference on Retroviruses and Opportunistic Infections (CROI)
Study confirms key therapeutic advance for children living with HIV and tuberculosis
Landmark study proves that 'super-boosting' approach counters negative interaction between key HIV and TB drugs The non-profit research and development organization Drugs for Neglected Diseases initiative (DNDi) has released results of a study in South Africa that will make it easier for healthcare workers to treat children living with HIV who are co-infected with tuberculosis (TB).

Contact: Ilan Moss
imoss@dndi.org
646-266-5216
Drugs for Neglected Diseases Initiative

Public Release: 14-Feb-2017
IDRI & NanoPass sign agreement to develop an intradermal rvRNA-based Zika virus vaccine
IDRI (Infectious Disease Research Institute) and NanoPass Technologies have signed a collaboration agreement to develop and test a new Zika vaccine based on a replicating viral RNA (rvRNA) construct administered intradermally using NanoPass's proprietary MicronJet600® microneedle device.

Contact: Lee Schoentrup
lee.schoentrup@idri.org
206-858-6064
Infectious Disease Research Institute

Public Release: 13-Feb-2017
Proceedings of the National Academy of Sciences
Disease 'superspreaders' were driving cause of 2014 Ebola epidemic
A new study about the overwhelming importance of 'superspreaders' in some infectious disease epidemics has shown that in the catastrophic 2014-15 Ebola epidemic in West Africa, about 3 percent of the people infected were ultimately responsible for infecting 61 percent of all cases. Researchers are now learning more about who these people are.
Bill and Melinda Gates Foundation, National Institutes of Health, UK Medical Research Council

Contact: Benjamin Dalziel
benjamin.dalziel@oregonstate.edu
541-737-1979
Oregon State University

Public Release: 10-Feb-2017
MD Anderson designated first Project ECHO superhub for oncology
Recognizing a critical need to address disparities in cancer care, The University of Texas MD Anderson Cancer Center has been designated as an ECHO superhub for oncology by the ECHO Institute at the University of New Mexico Health Science Center (UNMHSC). MD Anderson is one of just seven ECHO superhub sites in the world and the first focused on oncology.

Contact: Clayton R. Boldt, Ph.D.
crboldt@mdanderson.org
713-792-9518
University of Texas M. D. Anderson Cancer Center

Public Release: 10-Feb-2017
Nature Communications
Malaria vaccine target's invasion partner uncovered
A team at the Wellcome Trust Sanger Institute has discovered how a promising malarial vaccine target -- the protein RH5 -- helps parasites to invade human red blood cells. Published in Nature Communications, the study reveals that a previously mysterious protein on the surface of the parasite called P113 provides a molecular bridge between the parasite and a red blood cell. The discovery could be used to make a more effective malaria vaccine.
Wellcome Trust, Medical Research Council

Contact: Samantha Wynne
press.office@sanger.ac.uk
122-349-2368
Wellcome Trust Sanger Institute

Public Release: 10-Feb-2017
American Journal of Respiratory and Critical Care Medicine
Chinese air pollution linked to respiratory and cardiovascular deaths
In the largest epidemiological study conducted in the developing world, researchers found that as exposures to fine particulate air pollution in 272 Chinese cities increase, so do deaths from cardiovascular and respiratory diseases.
Public Welfare Research Program of National Health and Family Planning Commission of China, National Science Foundation of China, China Medical Board Collaborating Program

Contact: Dacia Morris
dmorris@thoracic.org
212-315-8620
American Thoracic Society

Public Release: 9-Feb-2017
Science
Why malaria mosquitoes like people with malaria
Malaria mosquitoes prefer to feed -- and feed more -- on blood from people infected with malaria. Researchers from Stockholm University, the Swedish University of Agricultural Sciences and KTH Royal Institute of Technology have discovered why. The findings can lead to new ways to fight malaria without using poisonous chemicals. The results will be published in the next issue of the journal Science.

Contact: Ingrid Faye
ingrid.faye@su.se
46-081-61272
Stockholm University

Public Release: 9-Feb-2017
$2 million grant to speed the development of new vector control products
LSTM's Department of Vector Biology has received a major grant from the Bill & Melinda Gates Foundation for a research programme to develop novel test protocols to accelerate development and bring to market, the next generation of vector control products.
The Bill & Melinda Gates Foundation

Contact: Clare Bebb
clare.bebb@lstmed.ac.uk
44-015-170-53135
Liverpool School of Tropical Medicine

Public Release: 9-Feb-2017
UMass Amherst research may lead to non-surgical cataract treatment
Early phase discoveries by polymer physicist Murugappan Muthukumar at UMass Amherst regarding the fundamental science of proteins in the lens of the human eye could revolutionize treatment of cataract and presbyopia.

Contact: Janet Lathrop
jlathrop@umass.edu
413-545-0444
University of Massachusetts at Amherst

Public Release: 9-Feb-2017
PLOS Computational Biology
Genetics of both virus and patient work together to influence the course of HIV infection
Viral and human genetics together account for about one third of the differences in disease progression rates seen among people infected with the human immunodeficiency virus (HIV), according to new research published in PLOS Computational Biology. The findings suggest that patient genetics influences disease progression by triggering mutations in the HIV viral genome.

Contact: Jacques Fellay
jacques.fellay@epfl.ch
PLOS

Public Release: 8-Feb-2017
Scientific Reports
A 'release and kill' strategy may aid treatment of tuberculosis
Mycobacterium tuberculosis hijacks human macrophages to evade immune destruction while preventing the macrophage from undergoing programmed cell death. This niche lets them grow in a protected environment that is hard to reach with antibiotics. In a proof-of-concept experiment, researchers were able to specifically force M. tuberculosis-infected macrophages into programmed cell death called apoptosis, thereby releasing the sheltered M. tuberculosis bacteria from the macrophage and expose them to a lethal dose of rifampicin antibiotic.
National Institutes of Health

Contact: Jeff Hansen
jeffhans@uab.edu
205-209-2355
University of Alabama at Birmingham

Public Release: 8-Feb-2017
Paediatrics and International Child Health
How Thailand eliminated mother-to-child HIV transmission
Thailand has become the first Asian country to eliminate mother-to-child transmission of HIV, thanks to a pragmatic multi-sector response backed by strong political commitment and heavy government investment, a study published in Paediatrics and International Child Health reports.

Contact: Sayjal Mistry
sayjal.mistry@informa.com
Taylor & Francis Group

Public Release: 7-Feb-2017
Inferface
New study is an advance toward preventing a 'post-antibiotic era'
New UCLA research may help to overcome life-threatening antibiotic-resistant bacteria in what the World Health Organization warns could become a 'post-antibiotic era.' UCLA biologists combined different classes of antibiotics to kill E. coli bacteria in their laboratory and found that certain combinations of three antibiotics are surprisingly effective in killing the bacteria and may be helpful in slowing the evolution of resistance to bacteria.

Contact: Stuart Wolpert
swolpert@support.ucla.edu
310-206-0511
University of California - Los Angeles

Public Release: 7-Feb-2017
Dissertations
Malaria control efforts can benefit from forecasting using satellites
Umeå University researcher Maquins Sewe has established links between patterns of malaria in Kenya and environmental factors (temperature, rainfall and land cover) measurable by satellite imagery. In his doctoral dissertation, the researcher shows that conducive environmental conditions occur before increases in hospital admissions and mortality due to malaria, indicating that the satellite information is useful for the development of disease forecasting models and early warning systems.

Contact: Daniel Harju
daniel.harju@umu.se
46-725-522-918
Umea University

Public Release: 6-Feb-2017
Nature Microbiology
Genes linked to malaria parasites' ability to persist in the body
The ability of malaria parasites to persist in the body for years is linked to the expression of a set of genes from the pir gene family, scientists from the Francis Crick Institute and the Wellcome Trust Sanger Institute have found. Their results are published today in Nature Microbiology.
Cancer Research UK, UK Medical Research Council, Wellcome

Contact: Francis Crick Institute press office
press@crick.ac.uk
44-020-379-63095
The Francis Crick Institute

Public Release: 6-Feb-2017
International Journal of Epidemiology
Research finds flaws in studies of mass deworming efforts for children in poor countries
Research published in the International Journal of Epidemiology finds that three widely cited studies relating to mass deworming in Africa have substantial problems in their methods and analysis. The original researchers claimed that their results show long-term effectiveness of these mass deworming programs in developing countries, but this critical analysis concludes that the findings are unlikely to be as positive as previously reported.

Contact: Daniel Luzer
daniel.luzer@oup.com
Oxford University Press USA

Public Release: 5-Feb-2017
Scientific Reports
Queensland-led team develops effective economical Ebola treatment
An effective and economical treatment for Ebola patients has been developed by an international team led by Queensland researchers. The post-exposure treatment made with antibodies from horses could be used in the next Ebola outbreak.
Australian Infectious Diseases Research Centre

Contact: Alexander Khromykh
a.khromykh@uq.edu.au
61-733-467-219
University of Queensland

Public Release: 3-Feb-2017
Circulation
Number of children emerging as cardiovascular risk factor for both parents
Number of children is emerging as a novel factor that influences the risk for some cardiovascular diseases (CVD), and in some societies in both parents, according to Professor Vera Regitz-Zagrosek, chairperson of the European Society of Cardiology 'management of CVD During Pregnancy' guidelines task force.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 2-Feb-2017
PLOS Genetics
Scaled-up malaria control efforts breed insecticide resistance in mosquitoes
A genetic analysis of mosquito populations in Africa shows that recent successes in controlling malaria through treated bednets has led to widespread insecticide resistance in mosquitoes, according to a study led by Charles Wondji of the Liverpool School of Tropical Medicine, with Kayla Barnes, Gareth Weedall and colleagues in PLOS Genetics.

Contact: Charles Wondji
charles.wondji@lstmed.ac.uk
PLOS

Showing releases 526-550 out of 1406.

<< < 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 > >>